Simultaneous bilateral avascular necrosis of the humerus and femur in long COVID-19: a case report

Cover Page


Cite item

Full Text

Abstract

Background. The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has prompted the widespread use of corticosteroids as a treatment strategy, particularly in cases of severe pneumonia and cytokine storm. While this therapy has saved countless lives, its side effects have also been well-documented, including the development of avascular necrosis.

Case presentation. This case report presents a rare instance of simultaneous bilateral avascular necrosis (AVN) affecting both the humeral and femoral heads in a 49-year-old male patient recovering from severe COVID-19. The patient was treated with high-dose corticosteroids, receiving 1250 mg of prednisolone over five days during hospitalization for COVID-19 pneumonia. Six months after discharge, he developed persistent hip pain, which was later diagnosed as AVN in both femoral heads. During hyperbaric oxygen therapy, the patient reported new shoulder pain, and MRI confirmed stage III AVN in both humeral heads. The patient’s pain was managed with bilateral suprascapular nerve radiofrequency ablation and bilateral Pericapsular Nerve Group (PENG) blocks, which provided significant relief.

Conclusions. This case emphasizes the potential for corticosteroid-induced AVN, even months after treatment, and underscores the need for long-term monitoring of patients receiving corticosteroids for COVID-19. The involvement of four major joints highlights the severe musculoskeletal complications that can arise, supporting the importance of early diagnosis and timely intervention for pain relief.

About the authors

Mesut Bakır

Mersin University, Faculty of Medicine, Division of Algology

Author for correspondence.
Email: mesutbakir@gmail.com
ORCID iD: 0000-0002-3627-3882

MD. Assoc. professor

Турция, Mersin

Şebnem Rumeli

Mersin University, Faculty of Medicine, Division of Algology

Email: sebnemrumeli66@gmail.com
ORCID iD: 0000-0002-7042-6934

MD, Professor

Турция, Mersin

References

  1. Bahsoun A., Fakih Y., Zareef R., Bitar F., Arabi M. Corticosteroids in COVID-19: pros and cons. Front Med (Lausanne). 2023;10:1202504. doi: 10.3389/fmed.2023.1202504.
  2. Horby P., Lim W.S., Emberson J.R., Mafham M., Bell J.L., Linsell L. et al. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021;384(8):693-704. doi: 10.1056/NEJMoa2021436.
  3. Sakellariou E., Argyropoulou E., Karampinas P., Galanis A., Varsamos I., Giannatos V. et al. Comprehensive Review of COVID-19-Infection- and Steroid-Treatment-Associated Bone Avascular Necrosis: A Multi-Study Analysis. Diagnostics (Basel). 2024;14(3):247. doi: 10.3390/diagnostics14030247.
  4. Powell C., Chang C., Naguwa S.M., Cheema G., Gershwin M.E. Steroid induced osteonecrosis: An analysis of steroid dosing risk. Autoimmun Rev. 2010;9(11): 721-743. doi: 10.1016/j.autrev.2010.06.007.
  5. Koshi E.J., Young K., Mostales J.C., Vo K.B., Burgess L.P. Complications of Corticosteroid Therapy: A Comprehensive Literature Review. J Pharm Technol. 2022;38(6):360-367. doi: 10.1177/87551225221116266.
  6. Panin M.A., Petrosyan A.S., Hadjicharalambous K.K., Boiko A.V. Avascular necrosis of the femoral head after COVID-19: A case series. Traumatology and Orthopedics of Russia. 2022;28(1):110-117. (In Russian). doi: 10.17816/2311-2905-1687.
  7. Zhao F.C., Guo K.J., Li Z.R. Osteonecrosis of the femoral head in SARS patients: seven years later. Eur J Orthop Surg Traumatol. 2013;23(6):671-677. doi: 10.1007/s00590-012-1054-4.
  8. Koo K.H., Mont M.A., Cui Q., Hines J.T., Yoon B.H., Novicoff W.M. et al. The 2021 Association Research Circulation Osseous Classification for Early-Stage Osteonecrosis of the Femoral Head to Computed Tomography-Based Study. J Arthroplasty. 2022;37(6):1074-1082. doi: 10.1016/j.arth.2022.02.009.
  9. Birla V., Vaish A., Vaishya R. Risk factors and pathogenesis of steroid-induced osteonecrosis of femoral head - A scoping review. J Clin Orthop Trauma. 2021;23:101643. doi: 10.1016/j.jcot.2021.101643.
  10. Xie X.H., Wang X.L., Yang H.L., Zhao D.W., Qin L. Steroid-associated osteonecrosis: Epidemiology, pathophysiology, animal model, prevention, and potential treatments (an overview). J Orthop Translat. 2015;3(2):58-70. doi: 10.1016/j.jot.2014.12.002.
  11. Parvizi J., Kim G.K. Chapter 22 - Avascular Necrosis. In: Parvizi J., Kim G.K., editors. High Yield Orthopaedics. Philadelphia: W.B. Saunders; 2010. p. 45-66.
  12. Lv H., de Vlas S.J., Liu W., Wang T.B., Cao Z.Y., Li C.P. et al. Avascular osteonecrosis after treatment of SARS: a 3-year longitudinal study. Trop Med Int Health. 2009;14 Suppl 1 (Suppl 1):79-84. doi: 10.1111/j.1365-3156.2008.02187.x.
  13. Kamani S., Lakhwani M.G., Phansopkar P. Undiagnosed Bilateral Avascular Necrosis of the Femur in a Young Male Caused by COVID-19 Steroid Injections. Cureus. 2022;14(10):e29982. doi: 10.7759/cureus.29982.
  14. Agarwala S.R., Vijayvargiya M., Pandey P. Avascular necrosis as a part of ‘long COVID-19’. BMJ Case Rep. 2021;14(7):e242101. doi: 10.1136/bcr-2021-242101.
  15. Moya-Angeler J., Gianakos A.L., Villa J.C., Ni A., Lane J.M. Current concepts on osteonecrosis of the femoral head. World J Orthop. 2015;6(8):590-601. doi: 10.5312/wjo.v6.i8.590.
  16. Chan K.L., Mok C.C. Glucocorticoid-induced avascular bone necrosis: diagnosis and management. Open Orthop J. 2012;6:449-457. doi: 10.2174/1874325001206010449.
  17. Li W., Huang Z., Tan B., Chen G., Li X., Xiong K. et al. General recommendation for assessment and management on the risk of glucocorticoid-induced osteonecrosis in patients with COVID-19. J Orthop Translat. 2021;31:1-9. doi: 10.1016/j.jot.2021.09.005.
  18. Velchov V., Georgiev P., Tserovski S., Tsenkov T., Alexiev V. Corticosteroid-Associated Avascular Necrosis of the Femoral Head in Patients with Severe COVID-19: A Single-Center Study. Med Sci Monit. 2023;29:e940965. doi: 10.12659/MSM.940965.
  19. Lohiya A. Jr., Dhaniwala N., Dudhekar U., Goyal S., Patel S.K. A Comprehensive Review of Treatment Strategies for Early Avascular Necrosis. Cureus. 2023;15(12):e50510. doi: 10.7759/cureus.50510.
  20. Wilson M., Bindler R.J., Stanek K., Layton M.E., Quock R.M. Hyperbaric Oxygen Therapy for Pain, Opioid Withdrawal, and Related Symptoms: A Pilot Randomized Controlled Trial. Pain Manag Nurs. 2022;23(5):616-624. doi: 10.1016/j.pmn.2022.03.001.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Eco-Vector

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 82474 от 10.12.2021.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies